Top Markets
Coin of the day
Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC
Ранг среди акций #28131
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Цена акции
$0.37430781
Последняя синхронизация: 2026-08-19
Рыночная капитализация
$28.37M
Изменение (1 день)
2.00%
Изменение (1 год)
-13.46%
Страна
CA
Торговля Defence Therapeutics Inc. (DTC)

Категория

Коэффициент P/B для Defence Therapeutics Inc. (DTC)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Defence Therapeutics Inc., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Defence Therapeutics Inc. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH